Loading...

Intellectia LogoIntellectia
AI Trading Bot
Features
Markets
News
Resources
Pricing
Get Started
  1. Home
  2. Stock
  3. BBUC
BBUC logo

BBUC Should I Buy

-
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
OverviewStock Price PredictionTechnicalValuationFinancialsEarningsShould I BuyNews & Events
an image of Intellectia Logoan image of Intellectia

Most Trusted AI Platform for Winning Trades

TwitterYoutubeQuoraDiscordLinkedinTelegram

Copyright © 2026 Intellectia.AI. All Rights Reserved.

Company

  • Home
  • Contact
  • About Us
  • Press
  • Privacy
  • Terms of Service
  • Service Terms of Use

Resources

  • Blog
  • Tutorial
  • Help Center
  • Affiliate Program

Markets

  • Market Analysis
  • Crypto
  • Featured Screeners
  • AI Earnings Calendar
  • Market Movers
  • Stock Monitor
  • Economic Calendar
  • All US Stocks
  • All Cryptos

Tools

  • Dividend Calculator
  • Dividend Yield Calculator
  • Options Profit Calculator

Features

  • QuantAI Alpha Pick
  • SwingMax Portfolio
  • Swing Trading
  • AI Stock Picker
  • Whales Auto Tracker
  • Daytrading Center
  • Patterns Detection
  • AI Screener
  • Financial AI Agent
  • Backtesting Playground
  • AI Earnings Prediction
  • Stock Monitor
  • Technical Analysis

News

  • Overview
  • Top News
  • Daily Market Brief
  • Earnings Analysis
  • Newswire
  • Stock News
  • Crypto News
  • Institution News
  • Congress News
  • Monitor News

Compare

  • TradingView
  • SeekingAlpha
Intellectia

Should You Buy Brookfield Business Holdings Corp (BBUC) Today? Analysis, Price Targets, and 2026 Outlook.

Conclusion
Buy
Latest Price
33.090
1 Day change
3.70%
52 Week Range
38.250
Analysis Updated At
2026/06/18
Should I buy Analysis is updated weekly. For real time "Should I Buy" analysis, please sign up to get free answers.

Brookfield Business Holdings Corp (BBUC) is a good buy for a beginner investor with a long-term strategy and $50,000-$100,000 available for investment. The stock has shown positive price momentum recently, analysts view the current weakness as a buying opportunity, and the company is making strategic moves to enhance its cash flow. While technical indicators are mixed, the overall sentiment and catalysts favor a long-term investment.

Technical Analysis

The MACD histogram is positive and expanding, indicating bullish momentum. RSI is neutral at 59.357, suggesting no overbought or oversold conditions. However, moving averages are bearish (SMA_200 > SMA_20 > SMA_5), showing a longer-term downtrend. The stock is trading near its resistance level (R1: 33.334), which could act as a short-term barrier.

Options Data

Bearish
Open Interest Put-Call Ratio
Bullish
Option Volume Put-Call Ratio

Technical Summary

StrongSellSellNeutralBuyStrongBuydotted line Image
Sell
5
Buy
8

Positive Catalysts

  • Analysts view the recent price weakness as a buying opportunity, with price targets ranging from $40 to $

  • Strategic sale of Multiplex for $650 million enhances cash flow and aligns with portfolio optimization.

  • Strong shareholder support demonstrated in the annual meeting.

Neutral/Negative Catalysts

  • Concerns around CDK challenges and Sagen's increasing loss ratio, as noted by analysts.

  • Bearish moving averages indicate a longer-term downtrend.

Financial Performance

Financial data unavailable for the latest quarter.

Growth

Profitability

Efficiency

Analyst Ratings and Price Target Trends

Analysts maintain an Outperform rating with revised price targets between $40 and $42. They view the recent selloff as an overreaction and a buying opportunity, citing confidence in the company's future growth prospects.

Wall Street analysts forecast BBUC stock price to rise
Analyst Rating
0
Wall Street analysts forecast BBUC stock price to rise
Buy
Hold
Sell
0
Current: 31.910
sliders
Low
0
Averages
0
High
0
0
Current: 31.910
sliders
Low
0
Averages
0
High
0
CIBC
Outperformer
maintain
$44
AI Analysis
2026-05-11
Reason
CIBC
Price Target
$44
AI Analysis
2026-05-11
maintain
Outperformer
Reason
CIBC lowered the firm's price target on Brookfield Business to $41.50 from $44 and keeps an Outperformer rating on the shares. The firm views the post-earnings selloff in the shares as a buying opportunity. Brookfield Business remains very confident in the future of Clarios and expects the business to double in value over the next five years, the analyst tells investors in a research note.
RBC Capital
Outperform
to
NULL
downgrade
$44 -> $40
2026-05-11
Reason
RBC Capital
Price Target
$44 -> $40
2026-05-11
downgrade
Outperform
to
NULL
Reason
RBC Capital lowered the firm's price target on Brookfield Business to $40 from $44 and keeps an Outperform rating on the shares. Shares traded down 8% post earnings which looks to have been driven by concerns around CDK experiencing challenges and Sagen's loss ratio increasing, the analyst tells investors in a research note.
Unlock Full Analyst Thesis, Get the complete breakdown of rating reason for BBUC
Unlock Now

People Also Watch